anmelden
SXI Bio+Medtech
4.850,16
PKT
-19,31
PKT
-0,40
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Bio+Medtech-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.05.05 | BB Biotech Kaufen | Geldbrief | |
| 26.05.05 | BB Biotech Kaufen | Geldbrief | |
| 18.05.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
| 02.05.05 | Lonza Reduce | Sarasin Research | |
| 03.05.05 | Lonza Buy | Helvea | |
| 26.04.05 | Straumann Outperform | Goldman Sachs | |
| 25.04.05 | Straumann Sector Perform | Vontobel | |
| 19.04.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
| 13.04.05 | Lonza Reduce | Sarasin Research | |
| 11.04.05 | Lonza Overweight | JP Morgan | |
| 07.04.05 | Lonza Reduce | Sarasin Research | |
| 23.03.05 | Kuros (Kuros Biosciences) Sector Outperform | Vontobel | |
| 21.03.05 | Tecan (N) Sector Perform | Vontobel | |
| 17.03.05 | Tecan (N) Reduce | Helvea | |
| 21.02.05 | Straumann Outperform | Goldman Sachs | |
| 21.02.05 | Straumann Accumulate | Helvea | |
| 21.02.05 | Straumann Underweight | Lehman Brothers | |
| 17.02.05 | Lonza Reduce | Sarasin Research | |
| 17.02.05 | Straumann Outperform | Credit Suisse First Boston | |
| 18.02.05 | Lonza Buy | Helvea | |
| 17.02.05 | Kuros (Kuros Biosciences) Neutral | Helvea | |
| 16.02.05 | Lonza Buy | Helvea | |
| 07.02.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
| 31.01.05 | Lonza Reduce | Sarasin Research | |
| 27.01.05 | Lonza Buy | Helvea | |
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 25.01.05 | Lonza Overweight | JP Morgan | |
| 24.01.05 | Straumann Outperform | Credit Suisse First Boston | |
| 24.01.05 | Lonza Reduce | Sarasin Research | |
| 19.01.05 | Straumann Accumulate | Helvea | |
| 19.01.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
| 19.01.05 | Tecan (N) Reduce | Helvea | |
| 18.01.05 | Lonza Buy | Helvea | |
| 17.01.05 | Lonza Reduce | Sarasin Research | |
| 17.01.05 | Tecan (N) Neutral | Credit Suisse First Boston | |
| 17.01.05 | Sonova Outperform | Credit Suisse First Boston | |
| 18.01.05 | Straumann Outperform | Credit Suisse First Boston | |
| 17.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
| 10.01.05 | Lonza Underperform | Goldman Sachs |